Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00915 |
| Species: | Homo sapiens |
| Position : | chr14:92450000-92451800 |
| Year: | 2014 |
| Title: | EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Ewing sarcoma |
| PMID: | 25453903 |
| MONDO: | MONDO:0003368 |
| Tissue: | Bone |
| Tissue Ontology ID: | UBERON:0001474 |
| Cell Source: | A673 Ewing sarcoma |
| CVCL ID: | CVCL_0080 |
| Cell Type: | Ewing sarcoma cell |
| Cell Ontology ID: | CL:0000050 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | VRK1 |
| TF name : | EWS-FLI1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|